Stock Analysis

Independent Non-Executive Director Ting Yuk Wu Sold A Bunch Of Shares In China Resources Medical Holdings

Published
SEHK:1515

Anyone interested in China Resources Medical Holdings Company Limited (HKG:1515) should probably be aware that the Independent Non-Executive Director, Ting Yuk Wu, recently divested HK$2.6m worth of shares in the company, at an average price of HK$4.41 each. Equally important, that sale actually reduced their holding by a full 100% which hardly makes us feel bullish about the stock.

See our latest analysis for China Resources Medical Holdings

The Last 12 Months Of Insider Transactions At China Resources Medical Holdings

Notably, that recent sale by Ting Yuk Wu is the biggest insider sale of China Resources Medical Holdings shares that we've seen in the last year. So what is clear is that an insider saw fit to sell at around the current price of HK$4.27. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

Ting Yuk Wu sold a total of 1.00m shares over the year at an average price of CN¥4.38. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

SEHK:1515 Insider Trading Volume May 21st 2024

I will like China Resources Medical Holdings better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Insider Ownership

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. From looking at our data, insiders own HK$9.6m worth of China Resources Medical Holdings stock, about 0.2% of the company. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. I generally like to see higher levels of ownership.

So What Does This Data Suggest About China Resources Medical Holdings Insiders?

An insider hasn't bought China Resources Medical Holdings stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. Insiders own relatively few shares in the company, and when you consider the sales, we're not particularly excited about the stock. We'd certainly practice some caution before buying! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing China Resources Medical Holdings. For example - China Resources Medical Holdings has 1 warning sign we think you should be aware of.

Of course China Resources Medical Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.